Ledger.Open graph →
SEC Form D · Amendment · filed December 30, 2019

Phoreus Biotechnology, Inc

Offering
$1.1M
Sold
$550K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
OLATHE, KS
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Matthew Tomich · New York, NYDirectorRandall Tosh · Olathe, KSExec · DirectorChristopher Brandt · Manhattan, KSDirectorXiomara Sinisterra-Hunter · Port Saint Lucie, FLDirectorMichael Coe · Logan, UTExec · DirectorNorman Leben · New York, NYDirectorCindy Croissant · Poulsbo, WADirectorSteven Alecia · New York, NYDirectorDavid Sze · San Francisco, CAExec · DirectorSteven Millner · New York, NYExec · DirectorGino Santini · Princeton, NJDirectorJoseph Pergolizzi · Naples, FLDirectorHerman Cukier · Princeton, NJDirectorJoseph Petko · Princeton, NJExec · DirectorDaniel Motto · Princeton, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗